Time- and cell-specific activation of BMP signaling restrains chondrocyte hypertrophy
Stephen J Gadomski,Byron W H Mui,Raphael Gorodetsky,Sriram S Paravastu,Joseph Featherall,Li Li,Abigail Haffey,Jae-Chun Kim,Sergei A Kuznetsov,Kathryn Futrega,Astar Lazmi-Hailu,Randall K Merling,NIDCD/NIDCR Genomics and Computational Biology Core,,Daniel Martin,Andrew W McCaskie,Pamela G Robey
DOI: https://doi.org/10.1016/j.isci.2024.110537
IF: 5.8
2024-07-18
iScience
Abstract:Stem cell therapies for degenerative cartilage disease are limited by an incomplete understanding of hyaline cartilage formation and maintenance. Human bone marrow stromal cells/skeletal stem cells (hBMSCs/SSCs) produce stable hyaline cartilage when attached to hyaluronic acid-coated fibrin microbeads (HyA-FMBs), yet the mechanism remains unclear. In vitro, hBMSC/SSC/HyA-FMB organoids exhibited reduced BMP signaling early in chondrogenic differentiation, followed by restoration of BMP signaling in chondrogenic IGFBP5 + /MGP + cells. Subsequently, human-induced pluripotent stem cell (hiPSC)-derived sclerotome cells were established (BMP inhibition) and then treated with transforming growth factor β (TGF-β) -/+ BMP2 and growth differentiation factor 5 (GDF5) (BMP signaling activation). TGF-β alone elicited a weak chondrogenic response, but TGF-β/BMP2/GDF5 led to delamination of SOX9 + aggregates (chondrospheroids) with high expression of COL2A1, ACAN, and PRG4 and minimal expression of COL10A1 and ALP in vitro. While transplanted hBMSCs/SSCs/HyA-FMBs did not heal articular cartilage defects in immunocompromised rodents, chondrospheroid-derived cells/HyA-FMBs formed non-hypertrophic cartilage that persisted until at least 5 months in vivo.